You are using an outdated browser and your browsing experience will not be optimal. Please update to the latest version of Microsoft Edge, Google Chrome or Mozilla Firefox. Install Microsoft Edge

September 1, 2020

Thailand Readies Draft Notification to Allow Hemp-Based Ingredients for Food Innovation

Subscribe to Updates
Informed Counsel

The cannabis industry in Thailand took its first concrete step in February of 2019, when medical cannabis was unexpectedly legalized. In August 2019, a Ministry of Public Health (MOPH) notification delisted some components and derivatives of cannabis plants from the category of narcotics and reclassified them as products within the purview of individual laws (e.g., on medicine, herbal products, cosmetics, food, etc.). Then, in October 2019, the Narcotics Control Committee clarified the legal definition of hemp in order to streamline the development of the hemp industry, which is not limited to medical applications. After months of inactivity in 2020, caused by the refocusing of attention on efforts to combat the COVID-19 outbreak, the Thai FDA recently circulated draft MOPH notifications that aim to govern hemp-based food ingredients under the Food Act.

Under these draft notifications, only non-viable hemp seeds, hemp seed oil, and protein derived from hemp seeds will be allowed as ingredients in food products. This means the development of food and food supplements comprising those ingredients is likely to be allowed soon. The key features of these drafts are provided below.

Products and Ingredients

In the present drafts, hemp seeds, hemp seed oil, proteins from hemp seeds (as defined in law), and food supplements containing these ingredients are classified as “specially controlled foods,” a product category associated with the highest risk under the Food Act B.E. 2522 (1979).

In addition to existing notifications on food contaminants, the drafts prescribe the maximum levels of impurities, such as cadmium and lead, that can be found in the hemp seeds. Moreover, the total THC must not exceed 5 ppm (that is, 5 milligrams per kilogram) in dry hemp seeds, and the CBD content must not exceed 30 ppm in dry hemp seeds. More standards are also proposed for hemp seed oil, proteins from hemp seeds, and various other hemp-based food products.

In the presentation of the products, statements claiming any type or amount of THC or CBD, or any health claims about these substances, are prohibited. On the other hand, a statement or claim about the hemp seed, hemp seed oil, or proteins from hemp seeds may be allowed, subject to rules prescribed in a separate notification pertaining to health claims in food products.

Notable label requirements include “May contain THC and CBD. Anyone with allergies or sensitivities to said substances should consume with caution,” and “No therapeutic properties.”

Cross-References to Other Regulations

Because these hemp-based food ingredients are derived from plants that can have narcotic qualities, some parts of the supply chain would still be governed by the Narcotics Act and its implementing regulations; particularly the upcoming Hemp Regulation, which is now at a relatively advanced stage in the review process for draft regulations. All relevant notifications and regulations should thus be read jointly to give a complete picture of the regulatory framework.

The present draft notifications on hemp-based food ingredients make a number of references to the future Hemp Regulation. For instance, it states that licensed food manufacturers who process viable (i.e. still narcotic) hemp seeds into non-viable hemp seeds (non-narcotic food ingredients) must also hold a separate hemp possession license under the Hemp Regulation. Similarly, to import viable hemp seeds into Thailand, an importer must hold a separate hemp importation license under the Hemp Regulation. However, the current draft Hemp Regulation places a five-year transitional restriction on the importation of hemp. It appears from a joint reading of the legislation that importation of viable hemp seeds, even for food production, is only likely to be allowed after the Hemp Regulation has been effective for five years.

Expected Developments

The draft notification on hemp-based food ingredients are currently in the public scoping period, which will end on September 21, 2020. Until then, comments may be submitted via the official website of the FDA’s Food Division (relevant contents in Thai only). The drafts are subject to further amendments following the scoping period.

Download Full Article
Related Professionals

Industries

Life Sciences

Practices

Regulatory Affairs

Location

RELATED INSIGHTS​ 

November 25, 2025
Food safety incidents can emerge without warning, requiring businesses to act swiftly to protect consumers and comply with regulatory obligations. Across Southeast Asia, Thailand, Vietnam, and Indonesia have each developed comprehensive food recall frameworks designed to ensure rapid removal of unsafe products from the market while holding businesses accountable for compliance failures. While these three jurisdictions share common objectives—protecting public health and ensuring food safety—each has crafted distinct regulatory approaches reflecting their unique administrative structures, enforcement priorities, and legal traditions. Understanding these differences is essential for food businesses operating in the region, as recall procedures, timelines, reporting requirements, and penalties vary significantly across borders. This guide, available through the button below, examines the food recall regulations in Indonesia, Thailand, and Vietnam, providing practical guidance on legal requirements, procedural steps, and compliance obligations in each market.
Read More
October 15, 2025
The Indonesian Food and Drug Administration (BPOM) has introduced more stringent oversight of health supplements containing probiotics with new guidelines that require clinical trials for certain products and expanded documentation standards. BPOM Regulation No. 17 of 2025 replaces the previous 2021 regulation and establishes a comprehensive framework for evaluating probiotic strains used in health supplements. Assessment Requirements The new regulation expands the scope of assessment to include not only categorization and documentation but also technical procedures, strain classification, and clinical trial requirements. Unlike the previous regulation, which provided general guidance, the updated framework creates a comprehensive system for evaluating both registered probiotic strains and new or combined strains. Manufacturers must now submit supporting documentation covering strain identification and functional characterization, safety, efficacy, and product quality. The previous regulation required documentation only on safety, efficacy, and quality. Clinical Trials One of the most significant changes is the requirement for clinical trials conducted in Indonesia for applications that include benefit claims other than maintaining digestive health, or where there are modifications to benefit claims. The regulation specifies that phase 1 trials must demonstrate safety, while phase 2 trials must validate efficacy using statistically valid methods such as double-blind, randomized, placebo-controlled studies). In addition, phase 3 and phase 4 trials may be required, and postmarket surveillance data must be submitted. Technical Assessment Framework Annex 4, a newly introduced section, establishes technical procedures for assessing health supplements containing probiotics in Indonesia. This comprehensive framework outlines criteria for evaluating new probiotic strains, including strain identification, functional characterization, safety, efficacy, and product quality. The annex introduces a clear classification of claims for health supplement products containing probiotics: General claims(e.g., maintaining digestive health). Functional claims(e.g., normal biological function or activity in the body). Risk reduction claims(e.g., lowering disease risk). The regulation restricts use of the term
Read More
October 3, 2025
On September 26, 2025, the Contract Committee under Thailand’s Consumer Protection Board issued a regulation that aims to standardize contracts and enhance consumer protection within the beauty and wellness industry. The Notification on Prescribing the Beauty Service Business as a Contract-Controlled Business B.E. 2568 (2025), which takes effect on January 24, 2026, requires business operators to use a prescribed standard contract in Thai and adhere to strict mandatory provisions and prohibitions. These regulations apply to operators across all in-person and online service channels, including via digital platforms. “Beauty services business” is defined as the provision of services under an agreement allowing consumers to receive a series of treatments, either over a set number of sessions or within a set period. This includes massage, spa, other methods for cleanliness, beauty, or care of facial or body skin, and weight control and body shaping—including services offered electronically. The law excludes surgery, liposuction, and medical treatments performed by licensed practitioners. The notification establishes the following key requirements: Mandatory contract and formatting. All contracts with consumers must use the standard contract form, in Thai, with clear, readable text (minimum font size of 2 millimeters, no more than 11 characters per inch), and include all essential terms from the annexed form. Contract execution. Contracts must be made in duplicate, with one copy given to the consumer at signing. For agreements concluded through electronic channels, the process must comply with the Electronic Transactions Act and use the same required terms. Digital platforms. Business operators who provide services facilitated through a digital platform as an intermediary are ultimately responsible for ensuring the consumer receives a compliant contract. Prohibited clauses. The law prohibits clauses that limit or exclude liability for damages to life, body, health, mind, or property resulting from breach of contract or a wrongful act;
Read More